Download free PDF

Preventive Healthcare Technologies and Services Market Size & Share 2024 to 2032

Market Size by Type (Early Detection and Screening, Chronic Disease Management Technologies, Vaccines, Advanced Technologies to Reduce Errors), End Use (Hospital, Clinics)– Global Forecast.

Report ID: GMI7106
   |
Published Date: October 2023
 | 
Report Format: PDF

Download Free PDF

Preventive Healthcare Technologies and Services Market Size

Preventive Healthcare Technologies and Services Market size was valued at USD 251.2 billion in 2023 and is set to grow at 10.3% CAGR from 2024 to 2032. These services refer to a range of medical tools, interventions, strategies, and healthcare practices that are designed to prevent the onset or progression of diseases before they become more serious or require more extensive treatment.

Preventive Healthcare Technologies and Services Market Key Takeaways

Market Size & Growth

  • 2023 Market Size: USD 251.2 Billion
  • 2032 Forecast Market Size: USD 605.3 Billion
  • CAGR (2024–2032): 10.3%

Key Market Drivers

  • Growing burden of chronic diseases.
  • Increasing adoption of digital healthcare technology.
  • Growing number of awareness programs by the government.
  • Advancement in preventive healthcare technology.

Challenges

  • Lack of healthcare IT professionals.
  • Stringent regulatory scenario.

The prevalence of chronic diseases, such as diabetes and obesity, has surged demand for these preventive services. For instance, according to WHO, chronic diseases are the leading cause of death globally, accounting for nearly 71% of all deaths worldwide. Thus, preventive measures help to mitigate the risk and reduce the impact of these conditions thereby accelerating the market progress.
 

Rising number of government awareness programs has increased popularity of preventive healthcare over the last decade. The Patient Protection and Affordable Care Act, commonly known as Obamacare, was enacted in 2010 and has mandated the inclusion of preventive healthcare services by insurance providers at no additional cost until now. Therefore, the private insurance companies are also currently shifting their focus on this market due to its enormous potential.
 

COVID-19 Impact

The COVID-19 pandemic led to a decrease in preventive screenings as the number of patient visits to healthcare facilities declined. The observational cohort study conducted in October 2021 indicated that COVID-19 had reduced the delivery of preventive care services, resulted in increased mortality, delayed diagnoses, and higher healthcare expenses. Consequently, COVID-19 had a significant commercial impact on the market.
 

Preventive Healthcare Technologies and Services Market

Preventive Healthcare Technologies and Services Market Trends

The demand for preventive healthcare technologies and services has increased owing to growing awareness among individuals about the benefits of preventive healthcare and the importance of regular health check-ups. Preventive care can be more cost-effective eventually, making it an attractive option for both healthcare providers and payers. Thus, contributing towards the market progress.

 

  • Additionally, telehealth and remote patient monitoring technologies have gained prominence, allowing patients to access healthcare services and monitoring them from the comfort of their homes. This reduces the need for in-person visits and can enhance preventive healthcare efforts.
     

Preventive Healthcare Technologies and Services Market Analysis

Preventive Healthcare Technologies and Services Market, By Type, (USD Billion)

 The market by type is categorized into early detection and screening, chronic disease management technologies, vaccines, advanced technologies to reduce errors. Early detection and screening segment is further segmented into automated screening, personalized medicine, other advanced screening technologies. This segment garnered USD 85 billion revenue size in the year 2022.
 

  • The highest share of the segment is primarily attributable to the benefits of personalized medical technologies, such as high accuracy and early disease or problem detection.
     
  • Technological advancements, such as improved diagnostic tools, telemedicine of which the market size reached USD 71.5 billion in 2022, wearable medical devices, and health monitoring apps, have made early detection and screening more accessible and accurate.
     
Preventive Healthcare Technologies and Services Market, By End-use (2023)

The preventive healthcare technologies and services market by end-use is categorized into hospitals, clinics, and others. Hospitals held over 41% of industry share in 2022.
 

  • Presence of skilled healthcare professionals, advanced equipment in hospital settings is projected to favor the business landscape.
     
  • Enhanced health coverage for hospital-based healthcare services from several private and group insurance plans, among others, is further projected to contribute towards market share.
     
U.S. Preventive Healthcare Technologies and Services Market, 2020- 2032 (USD Billion)

U.S. preventive healthcare technologies and services market accounted for USD 70.9 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

  • Technological advancements coupled with substantial healthcare expenditure are the factors driving the market growth. Increasing burden of chronic diseases among geriatric population further stimulates the demand for preventive healthcare technologies and services.
     
  • Major players in the industry are focusing on development of advanced preventive technologies which will create new opportunities for the country’s market growth.
     

Preventive Healthcare Technologies and Services Market Share

The preventive healthcare technologies and services industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Teladoc Health, holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Teladoc Health, introduced the Chronic Care Complete, a first-of-its-kind chronic condition management solution to help individuals recover their health outcomes.
 

Some of the eminent market participants operating in the preventive healthcare technologies and services industry include:

  • GlaxoSmithKline
  • Omnicell, Inc
  • Myriad Genetics
  • Omron Healthcare
  • Abbott Laboratories
  • Medtronic
  • Quest Diagnostics
  • Merck & Co. Inc.
  • Sanofi
  • NOVX Systems Corp
  • Moderna, Inc
  • Pfizer
  • Teladoc Health         
  • McKesson Corporation
  • Practice Fusion Inc.
     

Preventive Healthcare Technologies and Services Industry News:

  • In March 2022, GOQii Inc. secured USD 10 million in extended Series C funding with Animoca Brands as the investor. The capital infusion fueled the development of innovative healthcare solutions, leveraging blockchain tokens and gamification to enhance preventive healthcare offerings.
     
  • In January 2022, Healthlane introduced the Healthlane App, a sophisticated preventive healthcare technology designed to elevate and prolong the quality of medical care, ultimately with the aim of nurturing longer and healthier lives for individuals.
     

Preventive healthcare technologies and services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Type, 2018-2032 (USD Million)

  • Early detection and screening
  • Automated screening
  • Personalized medicine
  • Other advanced screening technologies 
  • Chronic disease management technologies
  • Blood pressure monitors
  • Asthma monitors
  • Cardiovascular monitors
  • Glucose monitors
  • Vaccines
  • Infectious diseases
  • Combined tetanus-diphtheria-pertussis vaccines
  • Allergy
  • Others
  • Advanced technologies to reduce errors
  • Electronic prescribing
  • Clinical decision support system
  • Smart infusion pumps
  • Computerized provider order entry system
  • Smart packaging
  • Automated prescription formulation & dispensing

By End-use, 2018-2032 (USD Million)

  • Hospitals
  • Clinics
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa

 

Authors:  Monali Tayade, Jignesh Rawal

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
How big is the preventive healthcare technologies and services market?
Preventive healthcare technologies and services industry size was USD 251.2 billion in 2023 and is estimated to reach USD 605.3 billion by 2032 owing to the growing prevalence of chronic diseases, such as diabetes and obesity.
How is the demand for preventive healthcare technologies and services driven in hospitals?
The hospitals end-use segment held over 41% of the preventive healthcare technologies and services industry share in 2022 propelled by the strong presence of skilled healthcare professionals.
What is the value of the U.S. preventive healthcare technologies and services market?
U.S. preventive healthcare technologies and services industry size was USD 70.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to rising technological advancements and substantial healthcare expenditure.
Who are the major preventive healthcare technologies and services industry players?
GlaxoSmithKline, Omnicell, Inc, Myriad Genetics, Omron Healthcare, Abbott Laboratories, Medtronic, Quest Diagnostics, Merck & Co. Inc., Sanofi, NOVX Systems Corp and Moderna, Inc. are some of the key preventive healthcare technologies and service providers.
Preventive Healthcare Technologies and Services Market Scope
  • Preventive Healthcare Technologies and Services Market Size

  • Preventive Healthcare Technologies and Services Market Trends

  • Preventive Healthcare Technologies and Services Market Analysis

  • Preventive Healthcare Technologies and Services Market Share

Authors:  Monali Tayade, Jignesh Rawal
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2023

Companies Profiled: 15

Tables & Figures: 400

Countries Covered: 18

Pages: 180

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)